List of biomarker patents
Patent 11543384 was granted and assigned to MOBILION SYSTEMS, INC. on January, 2023 by the United States Patent and Trademark Office.
Patent 11525783 was granted and assigned to IsoPlexis (company) on December, 2022 by the United States Patent and Trademark Office.
Patent 11322340 was granted and assigned to MOBILION SYSTEMS, INC. on May, 2022 by the United States Patent and Trademark Office.
Patent 11320436 was granted and assigned to Immunovia on May, 2022 by the United States Patent and Trademark Office.
Patent 11525832 was granted and assigned to Immunovia on December, 2022 by the United States Patent and Trademark Office.
Patent 11421264 was granted and assigned to IsoPlexis (company) on August, 2022 by the United States Patent and Trademark Office.
Patent 11162129 was granted and assigned to IsoPlexis (company) on November, 2021 by the United States Patent and Trademark Office.
Patent 11066689 was granted and assigned to IsoPlexis (company) on July, 2021 by the United States Patent and Trademark Office.
Patent 10584366 was granted and assigned to IsoPlexis (company) on March, 2020 by the United States Patent and Trademark Office.
Patent 10467748 was granted and assigned to Oxford Cancer Biomarkers on November, 2019 by the United States Patent and Trademark Office.
Patent 10827926 was granted and assigned to Cambridge Cognition Limited on November, 2020 by the United States Patent and Trademark Office.
Patent 10470708 was granted and assigned to Kokoon on November, 2019 by the United States Patent and Trademark Office.
Patent 9863960 was granted and assigned to Immunovia on January, 2018 by the United States Patent and Trademark Office.
Patent 9388469 was granted and assigned to Immunovia on July, 2016 by the United States Patent and Trademark Office.
Patent 8326396 was granted and assigned to Brain Products GmbH on December, 2012 by the United States Patent and Trademark Office.
Patent 10048265 was granted and assigned to Immunovia on August, 2018 by the United States Patent and Trademark Office.
Patent 10564163 was granted and assigned to Immunovia on February, 2020 by the United States Patent and Trademark Office.
Patent 11149309 was granted and assigned to IsoPlexis (company) on October, 2021 by the United States Patent and Trademark Office.
